Clinical Trial Update: Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial update for Additive Pharmacotherapy Treatment (ADAPT-2) in methamphetamine use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Methamphetamine Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2021-03-29